HEADER CHAPERONE 02-JUN-04 1W09 TITLE SOLUTION STRUCTURE OF THE CIS FORM OF THE HUMAN ALPHA-HEMOGLOBIN TITLE 2 STABILIZING PROTEIN (AHSP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-HEMOGLOBIN STABILIZING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 3-94; COMPND 5 SYNONYM: ERYTHROID ASSOCIATED FACTOR, ERYTHROID DIFFERENTIATION COMPND 6 RELATED FACTOR; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: ASP 29-PRO 30 PEPTIDE BOND IN CIS CONFORMATION SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PRSET (A) KEYWDS AHSP NMR STRUCTURE, PROLINE CIS/TRANS ISOMERIZATION, ALPHA- KEYWDS 2 THALASSAEMIA, ALPHA-HEMOGLOBIN BINDING, CHAPERONE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.M.SANTIVERI,J.M.PEREZ-CANADILLAS,M.K.VADIVELU,M.D.ALLEN, AUTHOR 2 T.J.RUTHERFORD,N.A.WATKINS,M.BYCROFT REVDAT 5 02-MAY-18 1W09 1 JRNL REMARK REVDAT 4 24-JAN-18 1W09 1 SOURCE REVDAT 3 24-FEB-09 1W09 1 VERSN REVDAT 2 03-MAY-05 1W09 1 JRNL REVDAT 1 10-JUN-04 1W09 0 JRNL AUTH C.M.SANTIVERI,J.M.PEREZ-CANADILLAS,M.K.VADIVELU,M.D.ALLEN, JRNL AUTH 2 T.J.RUTHERFORD,N.A.WATKINS,M.BYCROFT JRNL TITL NMR STRUCTURE OF THE ALPHA-HEMOGLOBIN STABILIZING PROTEIN: JRNL TITL 2 INSIGHTS INTO CONFORMATIONAL HETEROGENEITY AND BINDING. JRNL REF J. BIOL. CHEM. V. 279 34963 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15178680 JRNL DOI 10.1074/JBC.M405016200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE REMARK 4 REMARK 4 1W09 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1290020064. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0; 298.0 REMARK 210 PH : 6.0; 6.0 REMARK 210 IONIC STRENGTH : 120; 120 REMARK 210 PRESSURE : 1.0 ATM; 1.0 ATM REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : HSQC; HNCO; HNCACO; HNCACB; REMARK 210 CBCACONH; HCCH-COSY; DQF- COSY; REMARK 210 TOCSY; NOESY; 3D- 15N-HSQC-NOESY; REMARK 210 3D-13C-HSQC- NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, ANSIG FOR WINDOWS REMARK 210 WINDOWS REMARK 210 METHOD USED : CNS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 40 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NO DISTANCE VIOLATIONS WERE REMARK 210 GREATER THAN 0.3 A, NO ANGLE REMARK 210 VIOLATIONS WERE GREATER THAN 5.0 REMARK 210 DEGREES, AND NO RDC VIOLATIONS REMARK 210 WERE GREATER THAN 2.5 HZ REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTS AS A CHAPERONE TO PREVENT THE HARMFUL AGGREGATION OF REMARK 400 ALPHA-HEMOGLOBIN DURING NORMAL ERYTHROID CELL DEVELOPMENT. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 4 116.10 61.64 REMARK 500 1 GLN A 55 45.19 -102.71 REMARK 500 2 GLN A 25 162.59 -48.56 REMARK 500 2 GLN A 55 45.13 -105.54 REMARK 500 3 LEU A 4 -89.64 54.05 REMARK 500 3 GLN A 25 33.24 -71.07 REMARK 500 3 VAL A 26 120.92 24.86 REMARK 500 3 HIS A 92 107.63 -59.62 REMARK 500 4 LEU A 4 28.01 -161.12 REMARK 500 4 GLN A 25 162.41 -49.40 REMARK 500 4 GLU A 93 101.36 -51.34 REMARK 500 5 GLN A 25 160.09 -46.90 REMARK 500 5 LEU A 31 144.67 72.55 REMARK 500 5 GLU A 93 103.04 -52.67 REMARK 500 6 GLU A 93 86.68 -51.67 REMARK 500 7 GLN A 25 60.96 -46.27 REMARK 500 7 VAL A 26 102.62 27.96 REMARK 500 7 GLN A 55 34.21 -93.71 REMARK 500 8 GLN A 25 34.59 -70.25 REMARK 500 8 VAL A 26 115.32 31.93 REMARK 500 8 LEU A 31 -156.00 -157.71 REMARK 500 8 GLN A 55 46.21 -97.53 REMARK 500 8 GLU A 93 91.30 -52.64 REMARK 500 9 GLN A 25 42.23 -67.05 REMARK 500 9 VAL A 26 124.09 -6.79 REMARK 500 9 GLN A 55 46.10 -94.17 REMARK 500 9 GLU A 59 65.11 -110.57 REMARK 500 9 HIS A 92 104.86 -56.00 REMARK 500 9 GLU A 93 83.49 -63.27 REMARK 500 10 GLN A 25 162.73 -49.47 REMARK 500 10 GLN A 55 43.21 -107.01 REMARK 500 11 LEU A 4 36.78 34.21 REMARK 500 11 VAL A 26 111.20 121.48 REMARK 500 11 GLN A 55 46.16 -100.18 REMARK 500 11 GLU A 93 99.35 -54.86 REMARK 500 12 GLN A 25 37.08 -66.01 REMARK 500 12 VAL A 26 112.19 31.60 REMARK 500 13 LEU A 4 -50.46 -132.23 REMARK 500 13 VAL A 26 119.39 120.57 REMARK 500 13 LEU A 31 136.39 68.79 REMARK 500 14 GLN A 25 -36.18 64.44 REMARK 500 14 VAL A 26 109.62 80.91 REMARK 500 14 GLN A 55 47.15 -93.60 REMARK 500 14 HIS A 92 175.33 -52.71 REMARK 500 15 GLN A 25 37.25 -66.25 REMARK 500 15 VAL A 26 125.67 15.24 REMARK 500 15 GLN A 55 43.72 -104.89 REMARK 500 15 HIS A 92 104.92 -57.97 REMARK 500 16 LEU A 4 -79.01 34.41 REMARK 500 16 GLN A 25 160.22 -48.38 REMARK 500 REMARK 500 THIS ENTRY HAS 58 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1W0A RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE TRANS FORM OF THE HUMAN ALPHA-HEMOGLOBIN REMARK 900 STABILIZING PROTEIN (AHSP) REMARK 900 RELATED ID: 1W0B RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN ALPHA- HEMOGLOBIN STABILIZING REMARK 900 PROTEIN (AHSP) P30A MUTANT DBREF 1W09 A 3 94 UNP Q9NZD4 AHSP_HUMAN 3 94 SEQRES 1 A 92 LEU LEU LYS ALA ASN LYS ASP LEU ILE SER ALA GLY LEU SEQRES 2 A 92 LYS GLU PHE SER VAL LEU LEU ASN GLN GLN VAL PHE ASN SEQRES 3 A 92 ASP PRO LEU VAL SER GLU GLU ASP MET VAL THR VAL VAL SEQRES 4 A 92 GLU ASP TRP MET ASN PHE TYR ILE ASN TYR TYR ARG GLN SEQRES 5 A 92 GLN VAL THR GLY GLU PRO GLN GLU ARG ASP LYS ALA LEU SEQRES 6 A 92 GLN GLU LEU ARG GLN GLU LEU ASN THR LEU ALA ASN PRO SEQRES 7 A 92 PHE LEU ALA LYS TYR ARG ASP PHE LEU LYS SER HIS GLU SEQRES 8 A 92 LEU HELIX 1 1 LEU A 4 GLN A 25 1 22 HELIX 2 2 SER A 33 GLN A 55 1 23 HELIX 3 3 GLU A 59 SER A 91 1 33 CISPEP 1 ASP A 29 PRO A 30 1 -0.15 CISPEP 2 ASP A 29 PRO A 30 2 -0.01 CISPEP 3 ASP A 29 PRO A 30 3 0.06 CISPEP 4 ASP A 29 PRO A 30 4 0.11 CISPEP 5 ASP A 29 PRO A 30 5 0.61 CISPEP 6 ASP A 29 PRO A 30 6 -0.05 CISPEP 7 ASP A 29 PRO A 30 7 0.09 CISPEP 8 ASP A 29 PRO A 30 8 0.18 CISPEP 9 ASP A 29 PRO A 30 9 0.09 CISPEP 10 ASP A 29 PRO A 30 10 0.34 CISPEP 11 ASP A 29 PRO A 30 11 0.06 CISPEP 12 ASP A 29 PRO A 30 12 0.10 CISPEP 13 ASP A 29 PRO A 30 13 0.43 CISPEP 14 ASP A 29 PRO A 30 14 -0.01 CISPEP 15 ASP A 29 PRO A 30 15 -0.11 CISPEP 16 ASP A 29 PRO A 30 16 0.05 CISPEP 17 ASP A 29 PRO A 30 17 0.42 CISPEP 18 ASP A 29 PRO A 30 18 -0.07 CISPEP 19 ASP A 29 PRO A 30 19 0.09 CISPEP 20 ASP A 29 PRO A 30 20 -0.04 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1